Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCH in Locally Advanced or Inflammatory Breast Cancer
NCT00118053Phase 2Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Apr 2005
- Primary completion
- Dec 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by University of Medicine and Dentistry of New Jersey. Started Apr 2005; status: terminated.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00118053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118053.